RSK2 protects mice against TNF-induced bone loss

  • Christina Böhm
  • Anja Derer
  • Roland Axmann
  • Ulrike Hillienhoff
  • Mario M Zaiss
  • Julia Luther
  • Christine Zech
  • Michael Stock
  • Carina Scholtysek
  • Klaus Engelke
  • Andreas Hess
  • Jan P Tuckermann
  • Georg Schett
  • Jean-Pierre David

Abstract

Tumor necrosis factor (TNF)-α is a key cytokine regulator of bone and mediates inflammatory bone loss. The molecular signaling that regulates bone loss downstream of TNF-α is poorly defined. Here, we demonstrate that inactivating the pro-osteoblastogenic ERK-activated ribosomal S6 kinase RSK2 leads to a drastically accelerated and amplified systemic bone loss in mice ectopically expressing TNF-α [human TNF transgenic (hTNFtg) mice]. The phenotype is associated with a decrease in bone formation because of fewer osteoblasts as well as a drastically increased bone destruction by osteoclasts. The molecular basis of this phenotype is a cell autonomous increased sensitivity of osteoblasts and osteocytes to TNF-induced apoptosis combined with an enhancement of their osteoclast supportive activity. Thus, RSK2 exerts a strong negative regulatory loop on TNF-induced bone loss.

Bibliographical data

Original languageEnglish
ISSN0021-9533
DOIs
Publication statusPublished - 01.05.2012
PubMed 22344264